June 11th 2011
Ultra-precise radiation safe for prostate cancer
In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer.
Results of the trial, available in the Journal of Clinical Oncology, showed that stereotactic body radiation therapy (SBRT), which delivers ultra-precise radiation, was effective in treating patients with localized prostate cancer in five 30-minute sessions every other day over two weeks. That compares to the typical radiation protocol for prostate cancer of 42 to 45 daily treatments administered over eight to nine weeks. Read full post…
Tags: Radiation Safe, Safe
During the half-hour conference call meeting, Deputy Executive Director Matt Gianneschi told commissioners that Chief Academic Officer Cheryl Lovell will be leaving the department July 1. Before joining the department Lovell was a professor at the University of Denver. She’s been significantly involved in working with the Department of Education on implementation of the Colorado Achievement Plan for Kids law.